BiomX Inc. - PHGE
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Oct 06, 2026 | SCHEDULE 13D/A | — | 15.0% | 130,000 | View |
| Oct 05, 2026 | SCHEDULE 13G | Mandragola Ltd. | 9.99% | 553,800 | View |
| Oct 05, 2026 | SCHEDULE 13G | Gur Aryeh Segal | 9.99% | 553,800 | View |
| Sep 17, 2026 | SCHEDULE 13D | — | 15.0% | — | View |
| Sep 15, 2026 | SCHEDULE 13D/A | — | 3.87% | — | View |
| Aug 20, 2026 | SCHEDULE 13G/A | Cystic Fibrosis Foundation | 1.5% | 174,276 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 7.13% | 730,551 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Wilmot B. Harkey | 7.13% | 730,551 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Daniel Mack | 7.13% | 730,551 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Rodney Hodges | 0.7% | 82,618 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Geneva Holding Company (GHC) SA | 0.7% | 82,618 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Geneva Trust Company (GTC) SA | 0.7% | 82,618 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Centaurus Investments Limited | 0.7% | 82,618 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Telmina Limited | 0.7% | 82,618 | View |
| Jun 16, 2026 | SCHEDULE 13D/A | — | 2.37% | 11,160,153 | View |
| May 28, 2026 | SCHEDULE 13D/A | — | 4.08% | 10,783,794 | View |
| May 14, 2026 | SCHEDULE 13G/A | Rodney Hodges | 5.2% | 82,618 | View |
| May 14, 2026 | SCHEDULE 13G/A | POD Sarl | 5.2% | 82,618 | View |
| May 14, 2026 | SCHEDULE 13G/A | Geneva Holding Company (GHC) SA | 5.2% | 82,618 | View |
| May 14, 2026 | SCHEDULE 13G/A | Geneva Trust Company (GTC) SA | 5.2% | 82,618 | View |
| May 14, 2026 | SCHEDULE 13G/A | Centaurus Investments Limited | 5.2% | 82,618 | View |
| May 14, 2026 | SCHEDULE 13G/A | Telmina Limited | 5.2% | 82,618 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Alyeska Investment Group, L.P. | 2.5% | 38,176 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Alyeska Fund GP, LLC | 2.5% | 38,176 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Anand Parekh | 2.5% | 38,176 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 9.99% | 156,696 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Wilmot B. Harkey | 9.99% | 156,696 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Daniel Mack | 9.99% | 156,696 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | Orin Hirschman | 0.1% | 38,175 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | AIGH Capital Management LLC | 0.1% | 38,175 | View |
| Aug 07, 2025 | SCHEDULE 13G/A | Morgan Stanley | 0.0% | 0 | View |
| Aug 07, 2025 | SCHEDULE 13G/A | Morgan Stanley & Co. LLC | 0.0% | 0 | View |
| May 15, 2025 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 9.99% | 2,494,197 | View |
| May 15, 2025 | SCHEDULE 13G/A | Wilmot B. Harkey | 9.99% | 2,494,197 | View |
| May 15, 2025 | SCHEDULE 13G/A | Daniel Mack | 9.99% | 2,494,197 | View |
| Mar 04, 2025 | SCHEDULE 13G/A | Cystic Fibrosis Foundation | 9.99% | 2,494,110 | View |
| Feb 14, 2025 | SCHEDULE 13G/A | Cystic Fibrosis Foundation | 19.99% | 4,094,558 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.